Close
Close
Treatment Database
(6-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)pyrimidin-2-yl)-1-methyl-1H-indol-2-yl)(3,3-difluoroazetidin-1-yl)methanone
Trade Name not avaiable
Orphan Indication Idiopathic Pulmonary Fibrosis
USA Market Approval
USA Designation Date 08-05-2019
Sponsor Beijing Tide Pharmaceutical Co., Ltd
No.8 East Rongjing Street, Beijing Econnomic-technological Development Area (BDA)
Beijing
More about Idiopathic pulmonary fibrosis
Free Newsletter
Related Videos
by Abidemi Uruejoma
423 views